The world of pricing and reimbursement of pharmaceuticals is large and complex. Specificities related to the indication(s), market environment, available evidences, local regulations – and many other aspects – require tailored activities and first-rate expertise in order to achieve timely access to innovative treatments or assess their value potential. In addition to our own knowledge, specialist input into our market access consulting projects is derived from an international network of experts and opinion leaders. At forethought access, we encourage in-depth preliminary discussions with customers about the relevance of our expertise and project feasibility.